Fig. 7From: Integrated whole genome microarray analysis and immunohistochemical assay identifies COL11A1, GJB2 and CTRL as predictive biomarkers for pancreatic cancerValidation of COL11A1, GJB2 and CTRL with immunohistochemical assay of clinical samples a expression level of COL11A1, GJB and CTRL in 46 paired pancreatic cancer and para-cancerous tissue sections, b expression level of COL11A1 GJB2 and CTRL in different cancer stages, c survival analysis of patients with different expression level of COL11A1, GJB2 and CTRLBack to article page